Physician profile
Jerald Carmel
NPI 1770664401
$2,220.98
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $812 · 2020: $308 · 2021: $334 · 2022: $767.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $409.69 | 2022 | |
| Organogenesis INC. | $365.70 | 2019-2022 | |
| Smith+Nephew, INC. | $358.39 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $225.11 | 2021 | |
| Stryker Corporation | $172.90 | 2019-2020 | |
| Abbvie INC. | $124.99 | 2022 | |
| Cardiovascular Systems INC. | $90.56 | 2019 | |
| Grt US Holding, INC. | $90.27 | 2022 | |
| Zyla Life Sciences, INC. | $78.92 | 2019 | |
| Sebela Pharmaceuticals INC. | $42.97 | 2019-2021 | |
| Kci USA, INC. | $39.64 | 2021 | |
| Kerecis Limited | $38.25 | 2020 | |
| Integra Lifesciences Corporation | $36.85 | 2022 | |
| Bioventus LLC | $24.77 | 2019 | |
| Djo, LLC | $20.76 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $19.77 | 2019 | |
| Horizon Therapeutics Plc | $17.92 | 2021 | |
| Polarityte, INC. | $17.85 | 2019 | |
| Wright Medical Technology, INC. | $17.12 | 2019 | |
| Alfasigma USA, INC. | $16.05 | 2020 | |
| Assertio Therapeutics, INC. | $12.50 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerald Carmel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.